Biologics & Biosimilars
More biologic medications will become available soon in the U.S., creating options and access to more people. These “biosimilars” have been shown to be as effective and safe as existing biologics. Learn about the similarities and differences between biologics, unbranded biologics and new biosimilars.
"I think people should try to be reassured that these drugs are high quality. They are highly similar. The likelihood of them not doing exactly the same thing is infinitesimally low."
Mark Box, MDBiosimilars FAQs
What is a biosimilar?
How is a biosimilar different from other biologics?
Are biosimilars generic drugs?
Will biosimilars cost less?
What is an unbranded biologic?
10 Things to Know
Questions for Your Doctor
Our Position
Biologics Basics
Biosimilars Webinar
A rheumatologist discusses biosimilars, insurance coverage and out-of-pocket costs. He also explains “interchangeability” laws and how they might affect you if you currently take or might take biologic medications.
"We’ve been using medications that were biosimilars in the U.S. but it was … given in the infusion center as an IV. In 2023, the first patient-administered biosimilar will be available."
Angus B. Worthing, MDBiosimilars Podcast Episode
Biosimilars 101 & Inflammatory Arthritis
Access will soon expand for new biologic treatments for inflammatory arthritis called biosimilars. Learn what they are, what to expect when taking one, including safety and effectiveness, and how determine if they are right for you.
Listen Now